Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ewout M Baerveldt"'
Autor:
Emoke Rácz, Dorota Kurek, Marius Kant, Ewout M Baerveldt, Edwin Florencia, Sabine Mourits, Dick de Ridder, Jon D Laman, Leslie van der Fits, Errol P Prens
Publikováno v:
PLoS ONE, Vol 6, Iss 5, p e19806 (2011)
Psoriasis is characterized by hyperproliferation of keratinocytes and by infiltration of activated Th1 and Th17 cells in the (epi)dermis. By expression microarray, we previously found the GATA3 transcription factor significantly downregulated in lesi
Externí odkaz:
https://doaj.org/article/29378433bed34f2687c5267b85d2c84f
Is Telemedicine Suitable for Patients with Chronic Inflammatory Skin Conditions? A Systematic Review
Autor:
Wynanda A. van Enst, Ying Chao Weng, Sophie A. C. Wanten, Marieke M.B. Seyger, Ewout M. Baerveldt, Bernd W.M. Arents, Elke M.G.J. de Jong, Juul M.P.A. van den Reek
Publikováno v:
Acta Dermato-Venereologica, Vol 104 (2024)
Telemedicine, the provision of remote healthcare, has gained prominence, accelerated by the COVID-19 pandemic. It has the potential to replace routine in-person follow-up visits for patients with chronic inflammatory skin conditions. However, it rema
Externí odkaz:
https://doaj.org/article/5847ed69eac948f18b4afd6332ef6913
Autor:
P. M. G. Smeets, G. Tafuni, Ph.I. Spuls, G. E. van der Kraaij, A. M. van Huizen, D. Determann, Ewout M. Baerveldt, I. van Ee, M. Hageman, W. J. A. de Kort, M. Boshuizen
Publikováno v:
British journal of dermatology, 184(5), 981-983. Wiley-Blackwell
The British Journal of Dermatology
The British Journal of Dermatology
Autor:
Marlies Wakkee, Dirk J. Grünhagen, Ewout M. Baerveldt, Dominiek A. Monserez, Fabiënne H.J. Koekelkoren, Tamar Nijsten, Marc A.M. Mureau, Ellen R. M. de Haas, Sofie L. Roodbergen, Alexander P.W.M. Maat
Publikováno v:
JAAD Case Reports
JAAD Case Reports, 5(3), 267-270. Elsevier Inc.
JAAD Case Reports, 5(3), 267-270. Elsevier Inc.
In 2012 vismodegib (Erivedge), an oral hedgehog pathway inhibitor, was approved by the US Food and Drug Administration for the treatment of locally advanced or metastatic basal cell carcinoma (BCC).1 Marketing authorization, however, does not account
Publikováno v:
British Journal of Dermatology, 173(6), 1536-1539. Wiley-Blackwell Publishing Ltd
British journal of dermatology, 173(6), 1536-1539. Wiley-Blackwell
British journal of dermatology, 173(6), 1536-1539. Wiley-Blackwell
Currently available biologics for psoriasis target the function of TNF-α, IL-17A or IL-12/23 and include etanercept (anti-TNF receptor fusion protein), adalimumab and infliximab (anti-TNFα antibodies), anti-IL-17(receptor) molecules and ustekinumab
Autor:
Edwin Florencia, Ewout M. Baerveldt, Reno Debets, Marius Kant, Errol P. Prens, Dorota Kurek, Armanda J. Onderdijk
Publikováno v:
Journal of Immunology, 195(4), 1744-1752. American Association of Immunologists
Clinical improvement of psoriasis induced by IL-4 treatment has been ascribed to changes in dermal inflammatory cells, such as activation of Th2 cells and tolerization of dendritic cells by suppressing IL-23 production. The pathologic epidermal alter
Autor:
Jaap J. van Hellemond, Justin S. Kuilder, Mariana de Mendonça Melo, Pieter J. Wismans, Perry J.J. van Genderen, Ewout M. Baerveldt
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 22, Iss 11, Pp 2022-2024 (2016)
Emerging Infectious Diseases, 22(11), 2022-2024. Centers for Disease Control and Prevention (CDC)
Emerging Infectious Diseases, Vol 22, Iss 11, Pp 2022-2024 (2016)
Emerging Infectious Diseases, 22(11), 2022-2024. Centers for Disease Control and Prevention (CDC)
To the Editor: Cutaneous leishmaniasis (CL) is a protozoan disease transmitted by sand flies that usually runs a relatively mild course. Classic CL starts as a red papule at the place of the insect bite; it gradually enlarges into a painless nodule o
Autor:
E.M.G.J. de Jong, L.L.A. Lecluse, D. van der Kleij, Ewout M. Baerveldt, T. Rispens, Errol P. Prens, J.M.P.A. van den Reek, S.P. Menting, Gertjan Wolbink, Ph.I. Spuls
Publikováno v:
British journal of dermatology, 173(3), 855-857. Wiley-Blackwell
British Journal of Dermatology, 173, 3, pp. 855-7
British Journal of Dermatology, 173, 855-7
British Journal of Dermatology, 173(3), 855-857. Wiley-Blackwell Publishing Ltd
British Journal of Dermatology, 173, 3, pp. 855-7
British Journal of Dermatology, 173, 855-7
British Journal of Dermatology, 173(3), 855-857. Wiley-Blackwell Publishing Ltd
Several therapeutic antibodies are available for the treatment of chronic plaque type psoriasis. Ustekinumab (a monoclonal IL12/23 antagonist) is one of these antibodies (1) and it is currently being investigated for other indications. For adalimumab
Autor:
Ewout M. Baerveldt, D. Kurek, J.W.J. van Kilsdonk, Arne S. IJpma, Jon D. Laman, Patrick A. M. Jansen, Errol P. Prens, Armanda J. Onderdijk, Edwin Florencia, Marius Kant, Jeroen Bastiaans, P.J. van der Spek
Publikováno v:
British Journal of Dermatology. 168:990-998
BACKGROUND: Ustekinumab is a fully human anti-p40 monoclonal antibody which neutralizes interleukin (IL)-12 and IL-23, thereby interfering with T-helper (Th)1/Th17 pathways and keratinocyte activation, and is highly effective in the treatment of psor
Autor:
Wilfred F. J. van IJcken, Frank J. T. Staal, Marius Kant, Jon D. Laman, Emőke Rácz, Ewout M. Baerveldt, Sabine Mourits, Dick de Ridder, Errol P. Prens, Leslie van der Fits, Dorota Kurek, Zeliha Ozgur
Publikováno v:
Journal of Investigative Dermatology, 131(7), 1547-1558. Nature Publishing Group
Narrow-band ultraviolet-B (NB-UVB) phototherapy is an effective treatment for psoriasis. The molecular mechanisms underlying its efficacy are incompletely understood. To identify NB-UVB-induced molecular pathways that may account for its anti-inflamm